The gross imbalances of cancer research must be addressed - Global cancer-research ecosystems invest billions of dollars in the development of oncological medicines and technologies, such as robotics and radiotherapy, yet comparatively little into programmes that aim to advance affordable, equitable and high-quality care and outcomes. The extraordinary growth in public and private expenditure on cancer discovery science and technologies, fuelled by the huge profits of cancer biopharmaceutical companies, has failed to create more opportunities for research in neglected areas. #Cancer#CancerCare#CancerResearch#BigPharma#researchhttps://www.nature.com/articles/d41586-023-02609-2
@CharlieMcHenry This is partly because corporations/supposedly independent foundations that sell and promote petrochemicals fund a lot of cancer research. They do this for two reasons, the first and most important is to deflect responsibility from the petrochemical industries and the second is because lots of rich old White men live long enough to get cancer and want to throw money at a cure for themselves personally. (The cooption of breast cancer activism against petrochemical corporations to make it into corporate Pink Ribbon propaganda to sell carcinogenic shampoo is a pivotal moment when it comes to the environmental pollution, industrial carcinogens and how we think about and approach cancer as an individual responsibility we have personal control over rather than a public health issue that the government needs to take control of to prevent us from being poisoned by corporations.)
Add comment